Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Brealey, David ^a   Karyampudi, Sekhar ^a   Jacques, Thomas S ^b   Novelli, Marco ^b   Stidwill, Ray ^a   Taylor, Val ^a   Smolenski, Ryszard T ^c,d   Singer, Mervyn ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenosine 5 triphosphate; Complex I; Glutathione; Nitric oxide; Respiratory chain

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CREATININE; GLUTATHIONE; NITRATE; NITRIC OXIDE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BLOOD; BLOOD PRESSURE; CELL DEATH; CELL FUNCTION; CHRONIC DISEASE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; LIVER FUNCTION TEST; MALE; METABOLISM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; MUSCLE MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PATHOLOGY; PATHOPHYSIOLOGY; PERITONITIS; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; SEPSIS; SEPTIC SHOCK; TIME; UREA NITROGEN BLOOD LEVEL;

EID: 1342331785     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00432.2003     Document Type: Article

References (36)

1. Alonso d V, Diaz J, Serrano E, and Carbonell LF. Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30: 1782-1786, 2002.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, and Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
3. Beltran B, Orsi A, Clementi E, and Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol 129: 953-960, 2000.
4. Boekstegers P, Weidenhofer S, Pilz G, and Werdan K. Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection 19: 317-323, 1991.
5. Bolanos JP, Heales SJ, Peuchen S, Barker JE, Land JM, and Clark JB. Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic Biol Med 21: 995-1001, 1996.
6. Borutaite V, Budriunaite A, and Brown GC. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim Biophys Acta 1459:405-412, 2000.
7. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, and Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360: 219-223, 2002.
8. Brookes PS, Bolanos JP, and Heales SJ. The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett 446: 261-263, 1999.
9. Brown GC. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol Cell Biochem 174: 189-192, 1997.
10. Brown GC and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994.
11. Clark JB, Bates TE, Boakye P, Kuimov A, and Land JM. A Practical Approach to the Investigation of Metabolic Disease, edited by Turner AJ and Bachelor J. Oxford: IRL Press at Oxford Univ. Press, 1997, p. 151-174.
12. m for oxygen: implications for mitochondrial pathology. Biochim Biophys Acta 1459: 390-396, 2000.
13. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, and Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24: 1179-1183, 1996.
14. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216: 117-134, 1992.
15. Giovannoni G, Land JM, Keir G, Thompson EJ, and Heales SJ. Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann Clin Biochem 34: 193-198, 1997.
16. Hammarqvist F, Luo JL, Cotgreave IA, Andersson K, and Wernerman J. Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med 25: 78-84, 1997.
17. Heales SJR. The biochemical investigation of mitochondrial respiratory chain disorders. CPD Bulletin Clinical Biochemistry 1: 78-81, 1999.
18. Hearse DJ. Myocardial hibernation. A form of endogenous protection? Eur Heart J 18, Suppl A: A2-A7, 1997.
19. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, and Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230-1251, 1999.
20. Hoyert DL, Arias E, Smith BL, Murphy SL, and Kochanek KD. Deaths: final data for 1999. Natl Vital Stat Rep 49: 1-113, 2001.
21. Ince C and Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 27: 1369-1377, 1999.
22. Karyampudi S, Brealey D, Stidwill R, Taylor V, and Singer M. The effect of sepsis on the key glycolytic enzymes in a rodent model of organ failure. Intensive Care Med 28, Suppl: S96, 2002.
23. Kobayashi H, Nonami T, Kurokawa T, Kitahara S, Harada A, Nakao A, Sugiyama S, Ozawa T, and Takagi H. Changes in the glutathione redox system during ischemia and reperfusion in rat liver. Scand J Gastroenterol 27: 711-716, 1992.
24. Kreymann G, Grosser S, Buggisch P, Gottschall C, Matthaei S, and Greten H. Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 21: 1012-1019, 1993.
25. Lehrer-Graiwer JE, Firestein BL, and Bredt DS. Nitric oxide mediated induction of cytochrome c oxidase mRNA and protein in a mouse macrophage cell line. Neurosci Lett 288: 107-110, 2000.
26. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein determination with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
27. Nemeth I and Boda D. Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome. Intensive Care Med 27: 216-221, 2001.
28. Rees DD, Monkhouse JE, Cambridge D, and Moncada S. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br J Pharmacol 124: 540-546, 1998.
29. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, and Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520, 1989.
30. Riobo NA, Clementi E, Melani M, Boveris A, Cadenas E, Moncada S, and Poderoso JJ. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 359: 139-145, 2001.
31. Rosser DM, Stidwill RP, Jacobson D, and Singer M. Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 79: 1878-1882, 1995.
32. Schapira AH. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim Biophys Acta 1410: 159-170, 1999.
33. Singer M and Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp 66: 149-166, 1999.
34. Smolenski RT, Lachno DR, Ledingham SJ, and Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 527: 414-420, 1990.
35. Stewart VC, Sharpe MA, Clark JB, and Heales SJ. Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J Neurochem 75: 694-700, 2000.
36. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta Bioenergetics 1411: 437-455, 1999.